← FDA Drug Approvals (Drugs@FDA)
POTASSIUM PHOSPHATES
NDA · New Drug Application · Sponsor: CMP DEV LLC · Approved 2019-09-19
Drug application
- FDA Application #
NDA212121
- Application type
- New Drug Application
- Brand name
- POTASSIUM PHOSPHATES
- Generic name
- Potassium Phosphate, Dibasic
- Active ingredients
- POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- CMP DEV LLC
- First approval
- 2019-09-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown